Translate AMICOR contents if you like

Monday, July 31, 2017

Cholesterol in 2017

Treatment of Cholesterol in 2017

JAMA. Published online July 24, 2017. doi:10.1001/jama.2017.6753
Clinicians and patients may find recent studies relevant to decisions about lipid-lowering therapy to be perplexing. There are now, for the first time, 3 evidence-based options to modify atherosclerotic cardiovascular disease risk via lipid-lowering medications. With new information emerging, recent guidelines aging, and decisions needing to be made, this is an opportune time to review lipid-lowering therapy in the age of increasing evidence-based choice. The focus in this Viewpoint is on typical patients, not those with extreme phenotypes.
Lipid-Lowering Therapy to Reduce Risk of Atherosclerotic Cardiovascular Disease (ASCVD)

No comments: